Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

combination therapy

  • You have access
    In Vitro Elucidation of Drug Combination Synergy in Treatment of Pancreatic Ductal Adenocarcinoma
    KEVIN T. BUSH, AMELIE BOICHARD and IGOR F. TSIGELNY
    Anticancer Research April 2018, 38 (4) 1967-1977;
  • You have access
    Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer Cells
    GEUN-HYOUNG HA, DONG-YOUNG KIM, EUN-KYOUNG BREUER and CHUNG KWON KIM
    Anticancer Research March 2018, 38 (3) 1303-1310;
  • You have access
    Antimetastatic Efficacy of the Combination of Caffeine and Valproic Acid on an Orthotopic Human Osteosarcoma Cell Line Model in Nude Mice
    KENTARO IGARASHI, KEI KAWAGUCHI, TASUKU KIYUNA, TAKASHI MURAKAMI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research March 2017, 37 (3) 1005-1011;
  • You have access
    Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized Trial
    CESARE GRIDELLI, ANTONIO CHELLA, GIUSEPPE VALMADRE, GIACOMO ALLEGRINI, MATTEO BRIGHENTI, PAOLO BIDOLI, ANTONIO ROSSI, PAOLO MAIONE, MARIA RITA MIGLIORINO, SERENA RICCIARDI and FILIPPO DE MARINIS
    Anticancer Research December 2016, 36 (12) 6535-6540;
  • You have access
    The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells
    KAROLINA LAPINSKA, GENEVIEVE HOUSMAN, SHANNON BYLER, SARAH HEERBOTH, AMBER WILLBANKS, ANUJA OZA and SIBAJI SARKAR
    Anticancer Research November 2016, 36 (11) 5731-5742;
  • You have access
    TAS-102 an Emerging Oral Fluoropyrimidine
    JIEZHONG CHEN, MEI HAN and MUHAMMAD WASIF SAIF
    Anticancer Research January 2016, 36 (1) 21-26;
  • You have access
    Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine
    TOKUNBO YEROKUN and LEYTE L. WINFIELD
    Anticancer Research December 2015, 35 (12) 6419-6424;
  • You have access
    Transarterial Chemoembolization with Miriplatin plus Epirubicin in Patients with Hepatocellular Carcinoma
    AKINOBU TAWADA, TETSUHIRO CHIBA, YOSHIHIKO OOKA, NAOYA KANOGAWA, TOMOKO SAITO, TENYU MOTOYAMA, SADAHISA OGASAWARA, EIICHIRO SUZUKI, FUMIHIKO KANAI, MASAHARU YOSHIKAWA and OSAMU YOKOSUKA
    Anticancer Research January 2015, 35 (1) 549-554;
  • You have access
    Transcatheter Arterial Embolic Therapies for Hepatocellular Carcinoma: A Literature Review
    HIROKI NISHIKAWA, RYUICHI KITA, TORU KIMURA and YUKIO OSAKI
    Anticancer Research December 2014, 34 (12) 6877-6886;
  • You have access
    Effects of Targeting Endometrial Stromal Sarcoma Cells via Histone Deacetylase and PI3K/AKT/mTOR Signaling
    PING QUAN, FARID MOINFAR, IRIS KUFFERATH, MARKUS ABSENGER, TATJANA KUEZNIK, HELMUT DENK, KURT ZATLOUKAL and JOHANNES HAYBAECK
    Anticancer Research June 2014, 34 (6) 2883-2897;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire